Sertraline in Addition to Standard of Care Treatment for Coccidioidomycosis
Status:
Withdrawn
Trial end date:
2019-01-22
Target enrollment:
Participant gender:
Summary
In this study patients will be randomized 1:2 to receive either standard of care treatment or
standard of care + Sertraline 200mg/day for 2 weeks, then 400 mg/day for 50 weeks for
treatment of disseminated and meningeal coccidioidomycosis.